ENFN Stock - Enfusion, Inc.
Unlock GoAI Insights for ENFN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $201.61M | $174.53M | $150.35M | $111.70M | $79.56M |
| Gross Profit | $136.74M | $116.89M | $103.25M | $79.86M | $58.21M |
| Gross Margin | 67.8% | 67.0% | 68.7% | 71.5% | 73.2% |
| Operating Income | $6.16M | $11.95M | $-11,964,000 | $-275,884,000 | $6.07M |
| Net Income | $2.82M | $6.03M | $-13,263,000 | $-282,242,000 | $4.06M |
| Net Margin | 1.4% | 3.5% | -8.8% | -252.7% | 5.1% |
| EPS | $0.02 | $0.10 | $-0.16 | $-4.30 | $0.06 |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 10th 2024 | Morgan Stanley | Resumed | Overweight | $11 |
| February 28th 2024 | Goldman | Downgrade | Sell | $8← $9 |
| January 30th 2024 | JP Morgan | Downgrade | Underweight | $9← $11 |
| November 7th 2023 | UBS | Initiation | Neutral | $9 |
| April 3rd 2023 | Piper Sandler | Initiation | Neutral | $11 |
| March 15th 2023 | JP Morgan | Initiation | Neutral | $12 |
| January 4th 2023 | BofA Securities | Downgrade | Underperform | $10← $15 |
| January 3rd 2023 | Morgan Stanley | Upgrade | Overweight | $12← $13 |
| October 3rd 2022 | BofA Securities | Downgrade | Neutral | $15← $17 |
Earnings History & Surprises
ENFNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 3, 2025 | — | — | — | — |
Q3 2025 | Aug 4, 2025 | — | — | — | — |
Q2 2025 | May 8, 2025 | $0.06 | $-0.01 | -116.7% | ✗ MISS |
Q1 2025 | Mar 3, 2025 | $0.07 | $0.03 | -57.1% | ✗ MISS |
Q4 2024 | Nov 4, 2024 | $0.06 | $0.05 | -16.7% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $0.06 | $0.05 | -16.7% | ✗ MISS |
Q2 2024 | May 9, 2024 | $0.04 | $0.06 | +65.5% | ✓ BEAT |
Q1 2024 | Mar 12, 2024 | $0.06 | $0.04 | -33.3% | ✗ MISS |
Q4 2023 | Nov 7, 2023 | $0.05 | $0.04 | -20.0% | ✗ MISS |
Q3 2023 | Aug 8, 2023 | $0.05 | $0.04 | -20.0% | ✗ MISS |
Q2 2023 | May 9, 2023 | $0.04 | $0.03 | -27.1% | ✗ MISS |
Q1 2023 | Mar 7, 2023 | $0.02 | $0.03 | +36.4% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $0.01 | $0.02 | +50.0% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $0.02 | $0.04 | +100.0% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $0.47 | $0.03 | -93.6% | ✗ MISS |
Q1 2022 | Mar 24, 2022 | $0.97 | $0.55 | -43.5% | ✗ MISS |
Q4 2021 | Dec 2, 2021 | $0.04 | $0.03 | -18.9% | ✗ MISS |
Q3 2021 | Aug 18, 2021 | — | $0.06 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.07 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.19 | — | — |
Frequently Asked Questions about ENFN
What is ENFN's current stock price?
What is the analyst price target for ENFN?
What sector is Enfusion, Inc. in?
What is ENFN's market cap?
Does ENFN pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to ENFN for comparison